Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 (Q28277569)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
scientific article

    Statements

    Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 (English)
    0 references
    Per Olov Hedlund
    0 references
    Jan-Erik Damber
    0 references
    Inger Hagerman
    0 references
    Svein Haukaas
    0 references
    Peter Henriksson
    0 references
    Peter Iversen
    0 references
    Robert Johansson
    0 references
    Peter Klarskov
    0 references
    Finn Lundbeck
    0 references
    Finn Rasmussen
    0 references
    Eberhard Varenhorst
    0 references
    Jouko Viitanen
    0 references
    2008
    0 references
    42
    0 references
    3
    0 references
    220-9
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit